SBIR/STTR Research Award

Improved, Safer Alternatives to Semiconductor Quantum Dots

Award identifier 128aef9dfab91c66a7682a9e3297322b1c24d37e3a29eccd0cbd6ee21f450e77Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$749,885

Program and phase

SBIR · Phase II

Award year

2009

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
TDA RESEARCH, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
MK5ANJVWVZK7
Solicitation number
PHS2009-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The principal aim of this project is to create a new class of fluorophore materials that have quantum-dot like emission properties but do not contain any toxic elements. Bright emitting fluorophores are needed for newly emerging applications such as cellular and molecular imaging, and semiconductor quantum dot nanoparticles have many valuable attributes as potent fluorophores. However, there are serious emerging concerns with the safety of these nanoparticles due to the toxic elements and compounds they are made from. Our new materials will avoid the potential safety drawbacks of semiconductor nanoparticles by offering a platform material with quantum dot-like emission properties lacking the toxic metals present in nanoparticulate semiconductor quantum dots. Our new materials are readily modifiable for different applications as superior fluorophores for biological and biomedical labeling. In Phase I we completed a pilot study of our new materials, and in Phase II studies we will conduct larger-scale syntheses, full purification and detailed characterization our new materials. We will use the knowledge gained in Phase I to synthesize quantum dot materials more advanced and better performing than those demonstrated in Phase I. We will then evaluate important properties of our materials including quantum yields, photostability, and cytotoxicity, followed by critical comparison of the results to standard fluorophore dye molecules and nanoparticle agents. These steps will enable biomedical and commercial development of our new class of non-metal quantum dot fluorophore materials. PUBLIC HEALTH RELEVANCE: This research and development project will create a new class of highly potent and non-toxic fluorescent agents. These new materials will be useful for improving the diagnosis of disease and other conditions in tests with biomedical samples and eventually in patients.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

951 SBIR/STTR records share this UEI (1988–2026). Reported award amounts total $317,960,224. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Energy, National Aeronautics and Space Administration, Environmental Protection Agency, National Science Foundation, Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.